312 related articles for article (PubMed ID: 22259180)
41. A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.
Cimino-Mathews A; Sharma R; Illei PB; Vang R; Argani P
Am J Surg Pathol; 2014 Dec; 38(12):1689-96. PubMed ID: 25046342
[TBL] [Abstract][Full Text] [Related]
42. Clinical and cytopathological aspects in phyllodes tumors of the breast.
Pătraşcu A; Popescu CF; Pleşea IE; Bădulescu A; Tănase F; Mateescu G
Rom J Morphol Embryol; 2009; 50(4):605-11. PubMed ID: 19942954
[TBL] [Abstract][Full Text] [Related]
43. Spindle cell lesions of the breast--the pathologic differential diagnosis.
Tse GM; Tan PH; Lui PC; Putti TC
Breast Cancer Res Treat; 2008 May; 109(2):199-207. PubMed ID: 17636400
[TBL] [Abstract][Full Text] [Related]
44. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
[TBL] [Abstract][Full Text] [Related]
45. Phyllodes tumor of the breast. An immunohistochemical study of 28 cases with special attention to the role of myofibroblasts.
Aranda FI; Laforga JB; López JI
Pathol Res Pract; 1994 May; 190(5):474-81. PubMed ID: 7991467
[TBL] [Abstract][Full Text] [Related]
46. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
47. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
48. Comparative study of histological features between core needle biopsy and surgical excision in phyllodes tumor.
Choi J; Koo JS
Pathol Int; 2012 Feb; 62(2):120-6. PubMed ID: 22243782
[TBL] [Abstract][Full Text] [Related]
49. Connective tissue stromal changes in tumours and tumour-like lesions of the breast.
Pai MR; Pai KN; Rao RV; Naik R; Shankarnarayana ; Baliga P
Indian J Pathol Microbiol; 1999 Jul; 42(3):327-32. PubMed ID: 10862293
[TBL] [Abstract][Full Text] [Related]
50. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
[TBL] [Abstract][Full Text] [Related]
51. Phyllodes tumours of the breast--a retrospective study from 1982-2000 of 50 cases in Portsmouth.
Sotheran W; Domjan J; Jeffrey M; Wise MH; Perry PM
Ann R Coll Surg Engl; 2005 Sep; 87(5):339-44. PubMed ID: 16176692
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.
Tan WJ; Thike AA; Bay BH; Tan PH
Histopathology; 2014 May; 64(6):807-17. PubMed ID: 24438019
[TBL] [Abstract][Full Text] [Related]
53. CD117 and CD34 staining patterns in childhood benign mammary lesions.
Kaçar A; Paker I; Akbiyik F; Arikök AT; Mambet E
Turk Patoloji Derg; 2012; 28(1):31-7. PubMed ID: 22207429
[TBL] [Abstract][Full Text] [Related]
54. Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.
Jara-Lazaro AR; Akhilesh M; Thike AA; Lui PC; Tse GM; Tan PH
Histopathology; 2010 Aug; 57(2):220-32. PubMed ID: 20716164
[TBL] [Abstract][Full Text] [Related]
55. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
56. CD34, CD117, and actin expression in phyllodes tumor of the breast.
Chen CM; Chen CJ; Chang CL; Shyu JS; Hsieh HF; Harn HJ
J Surg Res; 2000 Dec; 94(2):84-91. PubMed ID: 11104647
[TBL] [Abstract][Full Text] [Related]
57. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
[TBL] [Abstract][Full Text] [Related]
58. An approach to the diagnosis of spindle cell lesions of the breast.
Rakha EA; Aleskandarany MA; Lee AH; Ellis IO
Histopathology; 2016 Jan; 68(1):33-44. PubMed ID: 26768028
[TBL] [Abstract][Full Text] [Related]
59. [A Case of Malignant Phyllodes Tumor Difficult to Distinguish from Spindle Cell Carcinoma].
Okazaki Y; Kashiwagi S; Asano Y; Goto W; Takada K; Morisaki T; Takashima T; Noda S; Onoda N; Ohsawa M; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2243-2245. PubMed ID: 28133283
[TBL] [Abstract][Full Text] [Related]
60. Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast.
Mehta R; Jain RK; Sneige N; Badve S; Resetkova E
J Clin Pathol; 2010 Aug; 63(8):744-7. PubMed ID: 20702478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
